Pillstats
Rx only · Strip · Ophthalmic

Fluorescein Sodium

Brands: C20h10na2o5 Fluorescein Sodium Ophthalmic Strips · Dry Eye Test · Glostrips · Fluorescein Sodium

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)1436141
US makers2 labelers
Packages8
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

641281912552025 Q12025 Q22025 Q32025 Q42026 Q1
198
Rx · 2026 Q1
214
Units dispensed
+360%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Nomax Inc.unknown5SUPPLYING
Vistamerica USAunknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 31, 2025
    RECALLRecall (Class II): CHNaO Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged as a) 100-count box, NDC 83851-100-10; b) 300-count box, …

    Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. — Recalling firm: Wizcure Pharmaa Private Limited — Distributed Nationwide in the USA

  • Apr 19, 2024
    RECALLRecall (Class II): GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only, a) 100 strips per carton, NDC 51801-…

    Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities. — Recalling firm: Nomax Inc — Nationwide in the USA

  • Apr 19, 2024
    RECALLRecall (Class II): GloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Only, 100 Sterile Strips per carton, Nomax…

    Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities. — Recalling firm: Nomax Inc — Nationwide in the USA

  • Apr 13, 2021
    RECALLRecall (Class III): Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of …

    Subpotent Drug — Recalling firm: Nomax Inc — Nationwide USA

  • Mar 24, 2015
    RECALLRecall (Class III): Fluorescein Sodium Ophthalmic Strips USP, 0.6 mg per strip, labeled as 1) Fluorescein GloStrips, individually wrapped s…

    Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of fluorescein present in the strips. — Recalling firm: Nomax Inc — Nationwide and Puerto Rico, Australia, Brazil, Canada, Chile, Colombia, Dominican Republic, Honduras, Iceland, Israel, …